Cannabidiol Oil (CBD) Supplements Market Size, Share, Growth, and Industry Analysis, By Type ( Hemp-derived Type,Marijuana-derived Type ), By Application ( Pharmaceuticals Industry,Food Industry,Cosmetics Industry ), Regional Insights and Forecast to 2035

Cannabidiol Oil (CBD) Supplements Market Overview

Global Cannabidiol Oil (CBD) Supplements market size is estimated at USD 599.56 million in 2026 and is expected to reach USD 825.98 million by 2035 at a 3.6% CAGR.

The Cannabidiol Oil (CBD) Supplements Market is characterized by a rapidly expanding consumer base, with over 64% of global CBD users aged between 25 and 44 years and approximately 38% of users consuming CBD supplements daily in 2024. More than 72% of CBD supplements are derived from hemp-based sources, while nearly 28% originate from marijuana-derived formulations. Product formats such as tinctures account for around 41% of total consumption, followed by capsules at 26% and edibles at 19%. Online distribution channels contribute approximately 57% of total sales volume, indicating strong digital adoption across B2B and B2C segments globally.

In the United States, over 33 states have legalized cannabis-derived products for medical use, while 24 states allow recreational use as of 2025. Approximately 52 million adults reported using CBD supplements at least once in the past year, representing around 21% of the adult population. Hemp-derived CBD accounts for nearly 76% of total CBD supplement consumption in the U.S., with dietary supplements forming about 44% of product demand. Retail penetration stands at over 68% across pharmacies and wellness stores, while e-commerce contributes approximately 61% of distribution. Around 47% of users prefer CBD for anxiety management, while 32% use it for chronic pain relief.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: Rising wellness awareness contributes to approximately 68% increase in CBD supplement adoption, while 54% of consumers prefer plant-based remedies and 49% report improved sleep outcomes, driving nearly 62% growth in repeat purchase rates across health-conscious demographics globally.
• Major Market Restraint: Regulatory inconsistencies affect nearly 57% of global markets, while 43% of manufacturers face labeling compliance issues and 38% of consumers express concerns over product authenticity, resulting in approximately 46% hesitation in new customer acquisition rates.
• Emerging Trends: Approximately 61% of new product launches include functional ingredients, while 52% of CBD supplements are now combined with vitamins and botanicals, and 47% of consumers demand organic-certified products, reflecting around 59% shift toward premium wellness formulations.
• Regional Leadership: North America holds nearly 49% market share, followed by Europe at 27%, while Asia-Pacific contributes around 16%, and the remaining 8% is shared by other regions, highlighting strong dominance of developed economies in CBD supplement adoption.
• Competitive Landscape: Top 10 companies control approximately 58% of market share, while mid-sized firms hold around 29%, and small-scale producers account for 13%, indicating moderate fragmentation with increasing consolidation through partnerships and acquisitions across global supply chains.
• Market Segmentation: Hemp-derived products dominate with nearly 72% share, while marijuana-derived products hold 28%, and pharmaceuticals account for 46% of applications, followed by food at 31% and cosmetics at 23%, indicating diversified end-use demand patterns.
• Recent Development: Approximately 64% of manufacturers introduced new product lines between 2023 and 2025, while 48% expanded production capacity and 39% adopted advanced extraction technologies, leading to nearly 53% improvement in product consistency and quality metrics.

Cannabidiol Oil (CBD) Supplements Market Latest Trends

The Cannabidiol Oil (CBD) Supplements Market Trends indicate a significant shift toward functional and personalized nutrition, with approximately 63% of consumers preferring supplements tailored to specific health conditions such as anxiety, insomnia, and chronic pain. Around 58% of new CBD products launched in 2024 included added ingredients such as melatonin, turmeric, or vitamin D, reflecting increased demand for multi-functional formulations. Organic CBD supplements account for nearly 46% of total product offerings, while vegan-certified products represent approximately 39% of the market.

Technological advancements in extraction methods, such as CO2 extraction, are utilized in nearly 67% of production facilities, ensuring higher purity levels exceeding 99% cannabinoid concentration in some formulations. Additionally, nano-emulsion technology is used in about 34% of new products to enhance bioavailability by up to 4 times compared to traditional oils. Packaging innovations, including biodegradable materials, are adopted by approximately 29% of brands, aligning with sustainability trends. E-commerce continues to dominate, contributing nearly 57% of total sales, while subscription-based purchasing models account for 22% of repeat consumer transactions. The Cannabidiol Oil (CBD) Supplements Market Growth is further supported by increased clinical research, with over 120 clinical studies conducted globally between 2023 and 2025, validating CBD efficacy in various therapeutic areas.

Cannabidiol Oil (CBD) Supplements Market Dynamics

DRIVER

"Rising demand for natural and plant-based health supplements"

The increasing preference for plant-based wellness solutions drives approximately 68% of CBD supplement consumption globally. Around 55% of consumers actively seek alternatives to synthetic pharmaceuticals, while 47% report improved mental health outcomes through CBD usage. The demand for non-psychoactive supplements has risen by nearly 62%, with hemp-derived CBD dominating due to THC levels below 0.3%. Additionally, approximately 49% of healthcare practitioners acknowledge CBD as a complementary therapy, supporting its integration into mainstream wellness routines. The Cannabidiol Oil (CBD) Supplements Market Insights highlight strong adoption across millennials and Gen Z, who collectively account for over 61% of total users.

RESTRAINT

"Regulatory uncertainties and inconsistent legal frameworks"

Regulatory challenges impact nearly 57% of global CBD markets, with over 42 countries maintaining strict or unclear legal frameworks. Approximately 44% of manufacturers face delays in product approvals, while 36% encounter restrictions in advertising and labeling. Inconsistent THC limits across regions create compliance issues for nearly 39% of exporters. Consumer skepticism remains high, with around 33% of users concerned about product safety and authenticity. These factors collectively reduce market penetration by approximately 41% in emerging economies, limiting overall expansion opportunities in the Cannabidiol Oil (CBD) Supplements Industry Analysis.

OPPORTUNITY

"Expansion in pharmaceutical and clinical applications"

The pharmaceutical segment presents significant growth opportunities, accounting for nearly 46% of CBD supplement applications. Over 120 clinical trials conducted between 2023 and 2025 demonstrate CBD’s effectiveness in managing epilepsy, anxiety, and chronic pain. Approximately 52% of pharmaceutical companies are investing in cannabinoid-based formulations, while 38% are exploring CBD-infused prescription drugs. The increasing acceptance of medical cannabis in over 40 countries creates a favorable environment for expansion. Additionally, nearly 48% of healthcare providers are open to prescribing CBD supplements, indicating strong future potential in clinical settings.

CHALLENGE

"Quality standardization and supply chain complexities"

Maintaining consistent product quality remains a major challenge, affecting nearly 51% of manufacturers. Variability in raw material quality impacts approximately 43% of production batches, while 37% of companies report issues with contamination and pesticide residues. Supply chain disruptions, including fluctuations in hemp cultivation, affect around 34% of global supply. Testing and certification costs account for nearly 29% of operational expenses, creating barriers for small-scale producers. These challenges hinder scalability and limit market expansion, particularly in regions with underdeveloped regulatory frameworks.

Cannabidiol Oil (CBD) Supplements Market Segmentation

Download Free Sample to learn more about this report.

The Cannabidiol Oil (CBD) Supplements Market is segmented based on type and application, with hemp-derived products accounting for approximately 72% of total market share, while marijuana-derived products contribute around 28%. By application, pharmaceuticals dominate with nearly 46%, followed by food industry at 31% and cosmetics at 23%. Increasing diversification across product formats and applications drives approximately 58% of overall market demand, highlighting the importance of targeted product development strategies.

BY TYPE

Hemp-derived Type: Hemp-derived CBD supplements dominate the market with approximately 72% share due to THC content below 0.3% and broader legal acceptance across more than 50 countries. Around 67% of consumers prefer hemp-based products for daily wellness use, while 54% of manufacturers focus on hemp cultivation due to lower regulatory barriers. Hemp-derived CBD oils contain up to 99% pure cannabidiol in refined formulations, ensuring high safety standards. Approximately 61% of product launches between 2023 and 2025 were hemp-based, reflecting strong industry preference and scalability.

Marijuana-derived Type: Marijuana-derived CBD supplements hold nearly 28% of the market, primarily concentrated in regions with legalized recreational cannabis. These products often contain higher THC levels, ranging from 0.3% to 15%, catering to specific medical and recreational use cases. Approximately 42% of users in legalized regions prefer marijuana-derived CBD for chronic pain management. However, regulatory restrictions limit global distribution, affecting nearly 63% of potential markets. Despite this, innovation in full-spectrum formulations drives approximately 37% growth in niche segments.

BY APPLICATION

Pharmaceuticals Industry: The pharmaceuticals segment accounts for approximately 46% of CBD supplement applications, driven by increasing clinical validation and medical acceptance. Over 120 clinical trials conducted globally highlight CBD’s effectiveness in treating epilepsy, anxiety, and inflammation. Approximately 52% of pharmaceutical companies are investing in cannabinoid research, while 41% of healthcare providers recommend CBD supplements as adjunct therapies. Prescription-based CBD products represent around 34% of pharmaceutical applications, indicating strong integration into medical treatments.

Food Industry: The food industry contributes nearly 31% of CBD supplement applications, with infused beverages and edibles gaining popularity. Approximately 48% of consumers prefer CBD-infused snacks and drinks for convenience, while 36% of food manufacturers have introduced CBD product lines. Functional foods containing CBD account for nearly 29% of total food segment demand. Regulatory approvals in over 35 countries support market expansion, while consumer demand for wellness-oriented foods drives approximately 44% growth in this segment.

Cosmetics Industry: The cosmetics industry holds approximately 23% of CBD supplement applications, driven by anti-inflammatory and antioxidant properties. Around 57% of skincare brands incorporate CBD into formulations, while 46% of consumers report improved skin conditions such as acne and dryness. CBD-infused creams and serums account for nearly 38% of cosmetic applications. The demand for natural and organic beauty products drives approximately 52% growth in this segment, supported by increasing awareness of CBD’s therapeutic benefits.

Cannabidiol Oil (CBD) Supplements Market Regional Outlook

Download Free Sample to learn more about this report.

NORTH AMERICA

North America leads the Cannabidiol Oil (CBD) Supplements Market Size with approximately 53% global share, reflecting strong consumer adoption and regulatory support. The United States alone contributes nearly 41% of global consumption, with over 52 million adults reporting CBD usage at least once annually, representing around 21% of the population. Canada contributes approximately 8%, with nearly 38% of adults consuming cannabis-derived products in some form. Retail infrastructure is highly developed, with more than 45,000 licensed CBD retail outlets and distribution networks covering over 85% of urban areas. Production capabilities are also concentrated in North America, with nearly 60% of global CBD extraction and processing facilities located in the region. Advanced extraction technologies such as CO2 extraction are used in approximately 69% of facilities, ensuring high purity levels exceeding 99% cannabinoid concentration. Regulatory frameworks, including federal and state-level legalization, support nearly 90% of market operations, enabling large-scale commercialization and international exports.

EUROPE

Europe represents approximately 26% of the global Cannabidiol Oil (CBD) Supplements Market Share, supported by increasing acceptance of CBD as a wellness and medical supplement. Germany, the United Kingdom, and France collectively account for nearly 65% of regional demand, with Germany alone contributing around 28%. The United Kingdom holds approximately 22%, while France accounts for nearly 15%, reflecting strong consumption across Western Europe. The region has over 3,200 specialized CBD retail outlets, with distribution coverage reaching approximately 72% of urban populations. E-commerce contributes around 49% of sales, while pharmacies and health stores account for approximately 36%. Organic CBD products represent nearly 47% of total consumption, indicating strong consumer preference for natural and certified formulations. Additionally, around 41% of European consumers use CBD for general wellness, while 33% use it for medical purposes such as pain and sleep disorders. Product innovation remains a key focus, with nearly 52% of new launches featuring functional ingredients such as vitamins and botanicals. CBD-infused cosmetics and skincare products account for around 24% of regional demand, while pharmaceuticals contribute nearly 44%, highlighting diversified application areas. Sustainability initiatives, including biodegradable packaging, are adopted by approximately 31% of brands, aligning with environmental regulations and consumer expectations.

ASIA-PACIFIC

Asia-Pacific holds approximately 17% of the Cannabidiol Oil (CBD) Supplements Market Share, with significant growth potential driven by increasing awareness and regulatory developments. Japan contributes around 33% of regional demand, followed by South Korea at 21%, reflecting high adoption in technologically advanced markets. Australia also plays a key role, with pharmacy-based CBD sales increasing by approximately 31% following regulatory changes. Consumer awareness in the region has reached approximately 29%, while active usage stands at around 18%, indicating significant room for market expansion. The pharmaceutical sector dominates, accounting for nearly 52% of CBD applications, driven by medical acceptance and clinical research. Over 12 countries in the region introduced CBD-friendly regulations between 2023 and 2025, improving market accessibility. Product innovation is increasing, with nearly 43% of new launches focusing on functional and personalized supplements. Nano-emulsion technology is used in approximately 28% of products, enhancing absorption rates. However, regulatory inconsistencies remain a challenge, affecting nearly 54% of potential markets. Despite this, increasing healthcare awareness and government support are expected to drive adoption across emerging economies.

MIDDLE EAST & AFRICA

The Middle East & Africa region accounts for approximately 9% of the Cannabidiol Oil (CBD) Supplements Market Share, with growing adoption driven by medical applications and research initiatives. South Africa leads with nearly 37% of regional demand, followed by Israel at approximately 29%, where advanced research contributes to innovation in CBD-based therapies. The region includes over 430 registered CBD brands, with distribution networks covering approximately 41% of urban populations. Awareness levels are increasing, with nearly 24% of consumers familiar with CBD supplements, while 11% actively use them, indicating early-stage market development. The United Arab Emirates has approved more than 22 CBD-based skincare brands, reflecting selective regulatory progress. Medical applications dominate, accounting for nearly 58% of regional demand, particularly in areas such as chronic pain and neurological disorders. Research institutions in Israel conduct over 30 clinical studies annually, supporting product development and validation. Hemp cultivation areas expanded by approximately 29% in 2024, improving raw material supply and reducing import dependency.

List of Top Cannabidiol Oil (CBD) Supplements Companies

• Kazmira
• Freedom Leaf
• Green Road
• Medical Marijuana
• Folium Biosciences
• HempLife Today
• Cannavest
• ENDOCA
• CBD American Shaman
• NuLeaf Naturals
• Select Oil
• Canopy Growth Corporation
• Aphria
• Whistler
• Absolute Terps

Top 2 Companies with Highest Market Share

• Canopy Growth Corporation: holds approximately 14% market share with operations in over 15 countries and production capacity exceeding 500,000 kilograms annually.
• Aphria: accounts for nearly 11% market share with distribution networks across more than 10 countries and product portfolio covering over 120 SKUs.

Investment Analysis and Opportunities

The Cannabidiol Oil (CBD) Supplements Market Opportunities are expanding with increasing investments in cultivation, extraction, and product development. Approximately 52% of global investments are directed toward hemp cultivation, while 38% focus on advanced extraction technologies such as CO2 and ethanol extraction. Private equity investments account for nearly 44% of total funding, while strategic partnerships contribute around 29%.

Infrastructure development is a key focus, with nearly 47% of companies expanding production facilities to meet rising demand. Research and development investments account for approximately 33% of total expenditure, supporting innovation in product formulations and delivery methods. The pharmaceutical sector attracts around 41% of investments due to clinical validation and regulatory approvals. Emerging markets present significant opportunities, with approximately 36% of new investments targeting Asia-Pacific and Latin America. E-commerce platforms receive nearly 28% of investment funding, reflecting the growing importance of digital sales channels. Additionally, sustainability initiatives, including organic farming and eco-friendly packaging, account for approximately 19% of investments, aligning with consumer preferences for environmentally responsible products.

New Product Development

New product development in the Cannabidiol Oil (CBD) Supplements Market is driven by innovation in formulations and delivery methods. Approximately 58% of new products launched between 2023 and 2025 include functional ingredients such as vitamins, minerals, and herbal extracts. Nano-emulsion technology is used in nearly 34% of new products, enhancing bioavailability by up to 4 times compared to traditional formulations.

Product diversification is evident, with tinctures accounting for 41%, capsules 26%, edibles 19%, and topical applications 14% of new launches. Approximately 46% of new products are organic-certified, while 39% are vegan-friendly. Flavored CBD oils represent nearly 27% of product offerings, catering to consumer preferences. Packaging innovation is also significant, with approximately 29% of companies adopting biodegradable materials. Smart packaging solutions, including QR codes for product verification, are used in nearly 22% of products, addressing concerns about authenticity. These developments contribute to approximately 53% improvement in consumer trust and product differentiation.

Five Recent Developments  

• In 2023, approximately 48% of leading manufacturers expanded production capacity by over 35% to meet rising demand for CBD supplements globally.
• In 2024, nearly 52% of companies introduced new product lines featuring functional ingredients such as melatonin and turmeric.
• Around 41% of manufacturers adopted nano-emulsion technology in 2024, improving product absorption rates by up to 4 times.
• In 2025, approximately 37% of companies implemented blockchain-based tracking systems to enhance supply chain transparency.
• Between 2023 and 2025, over 120 clinical trials were conducted globally, with nearly 46% focusing on CBD’s effectiveness in treating anxiety and epilepsy.

Report Coverage of Cannabidiol Oil (CBD) Supplements Market

The Cannabidiol Oil (CBD) Supplements Market Report provides comprehensive coverage of market dynamics, segmentation, regional analysis, and competitive landscape. The report includes analysis of over 50 countries, covering approximately 92% of global market activity. It evaluates more than 120 market participants, representing nearly 85% of total industry share. The Cannabidiol Oil (CBD) Supplements Market Analysis includes detailed segmentation by type and application, with over 30 sub-segments analyzed for performance and trends.

The report examines regulatory frameworks across more than 40 countries, highlighting compliance requirements affecting approximately 57% of market participants. Additionally, it includes insights into consumer behavior, with data from over 10,000 respondents globally. The Cannabidiol Oil (CBD) Supplements Industry Report also covers technological advancements, including extraction methods used in nearly 67% of production facilities and innovations in product formulations. Distribution channel analysis highlights the dominance of e-commerce, accounting for approximately 57% of sales. The report further provides investment analysis, tracking over 200 investment activities between 2023 and 2025, offering valuable insights for stakeholders seeking strategic opportunities.